Wegovy and operations: what you need to know before any procedure

The stomach-emptying problem and why anaesthetists care

General anaesthesia suppresses the reflexes that normally stop stomach contents entering the lungs. Standard pre-operative fasting rules (nothing to eat for six hours, clear fluids up to two hours before) are designed around a stomach that empties at a predictable rate. GLP-1 medicines like semaglutide change that rate significantly. Gastric emptying slows, sometimes substantially, which means the stomach may hold more at the point of surgery than it would in someone not taking the medicine.

The consequence is a risk of pulmonary aspiration: stomach contents reaching the airway while the patient is unconscious. Anaesthetists take this seriously. Several professional bodies, including the Royal College of Anaesthetists, began updating their guidance from 2023 onward, and the picture is still evolving. What is clear is that an anaesthetist who does not know you are on Wegovy cannot plan for it. That information gap is the real risk.

One practical thing worth doing right now: check the Patient Information Leaflet that came with your pen. It lists the surgical precaution explicitly. If you have misplaced yours, the NHS England guidance on weight-management injections covers this point and is publicly accessible in about a minute.

What the guidance actually says, and what it does not

NHS England's guidance states plainly that patients should tell their healthcare team, including the anaesthetist, that they take a GLP-1 or tirzepatide medicine before any surgical procedure. That is not a recommendation to stop the medicine. It is a requirement that the surgical team has the information they need.

Whether to pause Wegovy before surgery (and for how long) is a clinical judgement that depends on the type of procedure, the type of anaesthesia, the urgency of the surgery, and the individual patient's circumstances. Elective day-surgery under local anaesthesia sits in a very different risk category from major abdominal surgery under general anaesthesia. Your anaesthetist may advise continuing without any gap, or may recommend pausing for one or more weekly doses beforehand.

Because Wegovy is a once-weekly injection and semaglutide has a half-life of roughly a week, even a single missed dose reduces the active level in circulation measurably. Some anaesthetic teams use this window as a precaution; others assess on a case-by-case basis. There is currently no single universal protocol that applies to every patient and every operation. What there is, universally, is the expectation of disclosure.

For anyone weighing up their semaglutide options more broadly, knowing this aspect of treatment ahead of time is useful context rather than a barrier to starting.

The conversation to have, and with whom

Three conversations cover the ground. First, with whoever prescribed your Wegovy: let them know a procedure is planned. They can advise on timing relative to your injection schedule and document any pause formally. At nume, every repeat order is reviewed by a GPhC-registered prescriber before it is dispensed, which makes that review appointment the natural moment to raise it, no separate call needed.

Second, with your surgical team at the pre-operative assessment: list Wegovy alongside your other medicines, and if you want to understand how it can interact with other medicines you take, our page on Wegovy medication interactions is a good place to start before that conversation. Pre-op nurses record this information and it reaches the anaesthetist. If you are asked when you last injected, give the exact date. If you are not asked, volunteer it.

Third, if there is any uncertainty about what to do with your injection timing, check the administration guidance and contact your prescriber rather than making the call yourself. Missing a dose intentionally requires the same care as taking one.

One thing worth understanding is how long treatment typically continues: Wegovy is generally prescribed over an extended period, so a planned surgical pause is a relatively short interruption in a longer course, not a reason to stop treatment permanently.

Returning to treatment after surgery

Most patients restart Wegovy once they have recovered sufficiently and their surgical team is satisfied. What that point looks like varies: someone recovering from minor day surgery may resume their normal weekly schedule within days; someone who has had major abdominal surgery and is still on restricted oral intake will need individual guidance on timing.

The risk of restarting too quickly after surgery is primarily gastrointestinal, nausea and reduced tolerance for food are already common post-operatively, and semaglutide's appetite-suppressing effects compound them. Your prescriber can advise on whether to restart at your previous dose or step back briefly.

Post-operative nutrition also deserves attention. Adequate protein, hydration and gradual reintroduction of food matter for recovery generally; on a GLP-1 medicine, where appetite can remain suppressed, getting enough nutrition needs deliberate effort. This is not a self-manage situation, your surgical team and your prescriber should know what you are eating and how you are tolerating it.

If you are considering starting Wegovy and have surgery planned in the near future, that timing question is worth raising at consultation, and you can also use our page listing Wegovy locations to find where treatment is available near you. Our clinical team can factor it into the assessment. Check your eligibility and let our prescribers know about any planned procedures in your answers, it is exactly the kind of detail that shapes a safe, individualised treatment plan.